BDM burgundy diamond mines limited

bdm income opportunity from overseas r & d

  1. 319 Posts.
    lightbulb Created with Sketch. 18
    Just shot off a quick email to BDM on this exciting news:
    For full note see SPL release to ASX 1.25pm 22/11/12.

    Starpharma to recoup $6 million cash for OVERSEAS R&D

    Melbourne, Australia: Starpharma (ASX:SPL; OTCQX:SPHRY) today announced that following a submission to AusIndustry, it is eligible to receive approximately $6 million cash in R&D tax incentive for OVERSEAS R&D activities.

    Starpharma made a submission for an advance finding in relation to VivaGel® activities in June 2012, and AusIndustry has today notified the Company that its overseas R&D activities satisfy the required criteria under the 45% R&D Tax Incentive Program.

    Could Biodiem profit from this program?
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
2.2¢
Change
-0.001(4.35%)
Mkt cap ! $31.26M
Open High Low Value Volume
2.2¢ 2.2¢ 2.2¢ $1K 45.45K

Buyers (Bids)

No. Vol. Price($)
6 489140 2.1¢
 

Sellers (Offers)

Price($) Vol. No.
2.4¢ 383415 3
View Market Depth
Last trade - 15.36pm 12/09/2025 (20 minute delay) ?
BDM (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.